Because of their therapeutic safety, hydroxyethylstarch, gelatin and dextrans are among the most frequently used drugs in the world. Recent studies have shown that bleeding disorders, anaphylactic reactions and storage in the body depend decisively on the nature of the administered plasma substitute. Through interdisciplinary cooperation the "First European Volume Replacement Conference" has established indications for the use of individual plasma substitutes to improve the efficacy and therapeutic safety of volume replacement therapy.
Auflage
Softcover Reprint of the Original 1st 1998 ed.
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für Beruf und Forschung
Research
Illustrationen
23
23 s/w Abbildungen
X, 143 p. 23 illus.
Maße
Höhe: 235 mm
Breite: 155 mm
Dicke: 9 mm
Gewicht
ISBN-13
978-3-540-64187-2 (9783540641872)
DOI
10.1007/978-3-642-72170-0
Schweitzer Klassifikation
1 Albumin: To Use or Not to Use? Contemporary Alternatives?.- 2 Use of Gelatines as Volume Expanders in Shock and Trauma.- 3 Which Hydroxyethyl Starch for Which Indication?.- 4 Volume Replacement Therapy with Dextrans: Dextrans Still Useful in Volume Replacement?.- 5 Volume Replacement in the Critically Ill.- 6 Bleeding Complications and Hydroxyethyl Starch: Strategies of Prevention.- 7 Volume Replacement in Burn Patients.- 8 Use of Plasma Substitutes During Cardiac Surgery: Focus on Priming Solutions.- 9 Adverse Renal Effects of Colloidal Solutions.- 10 New Therapeutic Concepts Using Oxygen Carriers.
